Fifty years studying hiperlipidemias: The case of familial combined hyperlipidemia;Cincuenta años de estudio de las hiperlipidemias primarias: El caso de la hiperlipidemia familiar combinada

Investigacion Clinica

Volumn 51, Issue 2, 2010, Pages 145-158

  Aguilar Salinas, Carlos Alberto ^a   Gómez Díaz, Rita ^b   Tusié Luna, María Teresa ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UMAE Hospital de Especialidades   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Apolipoprotein B; Cholesterol; Familial combined hyperlipidemia; HDL cholesterol; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; TRANSCRIPTION FACTOR 7 LIKE 2; UPSTREAM STIMULATORY FACTOR 1; CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ATHEROGENESIS; CARBOHYDRATE METABOLISM; FAMILIAL HYPERLIPEMIA; GENE CONTROL; GENE EXPRESSION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVIEW; ANIMAL; ATHEROSCLEROSIS; BLOOD; DISEASE MODEL; FEMALE; GENETIC ASSOCIATION; GENETICS; HUMAN; MALE; MOUSE; XANTHOMATOSIS;

ANIMALS; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CHOLESTEROL; DISEASE MODELS, ANIMAL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPOPROTEINS; MALE; MICE; TRIGLYCERIDES; XANTHOMATOSIS;

EID: 78149235611     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Fredrickson DS, Levy RI. Familial hyperlipoproteinemia. En: The metabolic basis of inhereted disease. Ed Stanbury J, Wyngaarden J, Frederickson D. Mc Graw Hill Book Co. New York 3o. Edición 1972. P545-614.
2. Chasman DI, Pare G, Mora S, Hopewell JC, Peloso G, Clarke R, Cupples LA, Hamsten A, Kathiresan S, Mälarstig A, Ordovas JM, Ripatti S, Parker A, Miletich J, Ridker PM. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genomewide analysis. PLoS genet 5(11): e1000730. doi:10.1371/journal.pgen.1000730.
3. Davignon J, Genest J. Genetics of lipoprotein disorders. Endoc Metab Clin North Am 1998; 27:521-534.
4. Arner P. Is familial combined hyperlipidaemia a genetic disorder of adipose tissue? Curr Opin Lipidol 1997; 8:89-94.
5. Bredie SJ, Demacker PN, Stalenhoef AF. Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity. Eur J Clin Invest 1997; 27:802-811.
6. Aguilar-Salinas CA, Olaiz G, Valles V, Ríos JM, Gómez Pérez FJ, Rull JA, Rojas R, Franco A, Sepúlveda J. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nation wide survey. J Lipid Res 2001; 42:1298-1307. (Pubitemid 32744254)
7. Aguilar-Salinas CA, Huertas A, Tusie MT, Gómez-Pérez FJ, Rull JA. Hiperlipidemia familiar combinada. Rev Endocrinol Nutr 2002; 10:58-62.
8. Mc Neely M, Edwards K, Marcovina S, Brunzell J, Motulsky A, Austin M. Lipoprotein and apolipoliprotein abnormalities in familial combined hyperlipidemia. Atherosclerosis 2001; 159:471-481.
9. Austin M, McKnight B, Edward K. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20 year prospective study. Circulation 2000; 101:2777-2782.
10. Goldstein JL, Schrott HG, Hazzard WT, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II: genetic analysis of lipid levels in 176 families and delineation of a new inhereted disorder, combined hyperlipidemia. J Clin Invest 1973; 52:1544-1568.
11. Grundy SM, Chait A, Brunzell JD. Familial Combined Hyperlipidemia Workshop. Arteriosclerosis 1987; 7:203-207.
12. Valles V, Aguilar-Salinas CA, Gómez- Pérez FJ, Rojas R, Franco A, Olaiz G, Rull JA, Sepúlveda J. Apolipoprotein B and AI distribution in the Mexican urban adults: Results of a Nation-Wide Survey. Metabolism 2002; 51:560-568.
13. Zamora M, Aguilar-Salinas CA, Gomez- Pérez FJ. Prevalencia del síndrome metabólico en la hiperlipidemia familiar combinada. Rev Endocrinol Nutr 2004; 12:46-50.
14. Del Rincón-Jarero JP, Aguilar-Salinas CA, Guillén-Pineda LE, Gómez-Pérez FJ, Rull JA. Lack of agreement between the plasma lipid based criteria and the apoprotein B for the diagnosis of Familial Combined Hyperlipidemia (FCHL) in members of FCHL kindreds. Metabolism 2002; 51:218-224.
15. Aguilar-Salinas CA, Zamora M, Gómez- Díaz RA, Mehta R, Gómez-Pérez FJ, Rull JA. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis. Semin Vasc Med 2004; 4: 203-209.
16. Sniderman AD, Castro-Cabezas M, Ribalta J, Carmena R, de Bruin TWA, de Graaf JA. proposal to redefine familial combined hyperlipidemia-Third workshop on FCHL. Eur J Clin Invest 2002; 32:71-73.
17. Naukkarinen J, Ehnholm C, Peltonnen L. Genetics of familial combined hyperlipidemia. Cur Opinion Lipidol. 2006; 17:285-290.
18. Lee J, Lusis A, Pajukanta P. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond. Cur Opinion Lipidol. 2006; 17:101-109.
19. Huertas-Vázquez A, del Rincón-Jarero JP, Canizales-Quinteros S, Vega-Hernández G, Riba L, Ramírez- Jiménez S, Aguilar- Salinas CA, Gómez Pérez FJ, Tusié-Luna MT. Replication of linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in mexican families. Ann Hum Genet 2004; 68(pte5):419-427.
20. Huertas-Vazquez A, Aguilar-Salinas C, Lusis A, Cantor R, Canizales A, Lee J, Tusié-Luna MT. Familial combined hyperlipidemia in mexicans. Association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler Thromb Vasc Biol 2005; 25:1985-1991.
21. Plaisier CL, Horvath S, Huertas-Vazquez A, Cruz-Bautista I, Herrera MF, Tusie- Luna T, Aguilar-Salinas C, Pajukanta P. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Genet. 2009 Sep;5(9): e1000642. Epub 2009; Sep 11.
22. Huertas-Vazquez A, Plaisier C, Weissglas-Volkov D, Canizales-Quinteros S, Cruz-Bautista I, Nikkola E, Herrera- Hernandez M, Davila-Cervantes A, Tusie-Luna MT, Taskinen MR, Aguilar-Salinas CA, Pajukanta P. TCF7L2 is associated with high serum triglycerides and differentially expressed in adipose tissue in families with familial combined hyperlipidemia. Diabetologia 2008; 51:62-69.
23. Weissglas D, Huertas Vazquez A, Canizalez S, Suviolahti E, Lee J, Aguilar Salinas CA, Tusie-Luna MT, Pajukanta P. Common hepatic nuclear factor 4 alpha variants are associated with high serum lipid levels and the metabolic syndrome. Diabetes. 2006; 55:1970-1977.
24. Weissglas-Volkov D, Plaisier C, Huertas- Vazquez A, Cruz-Bautista I, Riaño-Barros D, Herrera-Hernandez M, Riba L, Cantor R, Sinsheimer J, Aguilar-Salinas CA, Tusie-Luna MT, Pajukanta P. Identification of two common variants contributing to serum apolipoprotein B levels in mexicans. Arteriosclerosis Thromb Vasc Biol 2010; 30: 353-359.
25. Purnell J, Kahn S, Schwartz R, Brunzell R. Relationship of insulin sensitivity and apoB levels to intrabdominal fat in subjects with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2001; 21:567-572.
26. Aguilar-Salinas CA, Barrett HP, Pulai j, Zhu X, Schonfeld G. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy. Arterioscler Thromb Vasc Biol 1997; 17:72-82.